- Original Articles Hemato-oncology Use of deferasirox, an iron chelator, to overcome imatinib resistance of chronic myeloid leukemia cells
- Dae Sik Kim, Yoo Jin Na, Myoung Hee Kang, Soo-Young Yoon, Chul Won Choi
- Korean J Intern Med. 2016;31(2):357-366.
 |
 |
 |
 |
 |
 |